Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery

Simon R Best, Shiwen Peng, Chi Mou Juang, Chien-Fu Hung, Drew Hannaman, John R. Saunders, Tzyy Choou Wu, Sara I. Pai

Research output: Contribution to journalArticle

Abstract

DNA vaccines are an attractive approach to eliciting antigen-specific immunity. Intracellular targeting of tumor antigens through its linkage to immunostimulatory molecules such as calreticulin (CRT) can improve antigen processing and presentation through the MHC class I pathway and increase cytotoxic CD8+ T cell production. However, even with these enhancements, the efficacy of such immunotherapeutic strategies is dependent on the identification of an effective route and method of DNA administration. Electroporation and gene gun-mediated particle delivery are leading methods of DNA vaccine delivery that can generate protective and therapeutic levels of immune responses in experimental models. In this study, we perform a head-to-head comparison of three methods of vaccination - conventional intramuscular injection, electroporation-mediated intramuscular delivery, and epidermal gene gun-mediated particle delivery - in the ability to generate antigen-specific cytotoxic CD8+ T cell responses as well as anti-tumor immune responses against an HPV-16 E7 expressing tumor cell line using the pNGVL4a-CRT/E7(detox) DNA vaccine. Vaccination via electroporation generated the highest number of E7-specific cytotoxic CD8+ T cells, which correlated to improved outcomes in the treatment of growing tumors. In addition, we demonstrate that electroporation results in significantly higher levels of circulating protein compared to gene gun or intramuscular vaccination, which likely enhances calreticulin's role as a local tumor anti-angiogenesis agent. We conclude that electroporation is a promising method for delivery of HPV DNA vaccines and should be considered for DNA vaccine delivery in human clinical trials.

Original languageEnglish (US)
Pages (from-to)5450-5459
Number of pages10
JournalVaccine
Volume27
Issue number40
DOIs
StatePublished - Sep 4 2009

Fingerprint

Papillomavirus Vaccines
DNA Vaccines
Electroporation
electroporation
Intramuscular Injections
Firearms
recombinant vaccines
intramuscular injection
calreticulin
Calreticulin
T-lymphocytes
immune response
T-Lymphocytes
antigens
Vaccination
neoplasms
Genes
vaccination
Antigen Presentation
genes

Keywords

  • Calreticulin (CRT)
  • DNA vaccine
  • Electroporation
  • Head and neck cancer
  • Human papillomavirus (HPV)

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery. / Best, Simon R; Peng, Shiwen; Juang, Chi Mou; Hung, Chien-Fu; Hannaman, Drew; Saunders, John R.; Wu, Tzyy Choou; Pai, Sara I.

In: Vaccine, Vol. 27, No. 40, 04.09.2009, p. 5450-5459.

Research output: Contribution to journalArticle

@article{14993a7802724f58b8133ecb4b2e8ff6,
title = "Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery",
abstract = "DNA vaccines are an attractive approach to eliciting antigen-specific immunity. Intracellular targeting of tumor antigens through its linkage to immunostimulatory molecules such as calreticulin (CRT) can improve antigen processing and presentation through the MHC class I pathway and increase cytotoxic CD8+ T cell production. However, even with these enhancements, the efficacy of such immunotherapeutic strategies is dependent on the identification of an effective route and method of DNA administration. Electroporation and gene gun-mediated particle delivery are leading methods of DNA vaccine delivery that can generate protective and therapeutic levels of immune responses in experimental models. In this study, we perform a head-to-head comparison of three methods of vaccination - conventional intramuscular injection, electroporation-mediated intramuscular delivery, and epidermal gene gun-mediated particle delivery - in the ability to generate antigen-specific cytotoxic CD8+ T cell responses as well as anti-tumor immune responses against an HPV-16 E7 expressing tumor cell line using the pNGVL4a-CRT/E7(detox) DNA vaccine. Vaccination via electroporation generated the highest number of E7-specific cytotoxic CD8+ T cells, which correlated to improved outcomes in the treatment of growing tumors. In addition, we demonstrate that electroporation results in significantly higher levels of circulating protein compared to gene gun or intramuscular vaccination, which likely enhances calreticulin's role as a local tumor anti-angiogenesis agent. We conclude that electroporation is a promising method for delivery of HPV DNA vaccines and should be considered for DNA vaccine delivery in human clinical trials.",
keywords = "Calreticulin (CRT), DNA vaccine, Electroporation, Head and neck cancer, Human papillomavirus (HPV)",
author = "Best, {Simon R} and Shiwen Peng and Juang, {Chi Mou} and Chien-Fu Hung and Drew Hannaman and Saunders, {John R.} and Wu, {Tzyy Choou} and Pai, {Sara I.}",
year = "2009",
month = "9",
day = "4",
doi = "10.1016/j.vaccine.2009.07.005",
language = "English (US)",
volume = "27",
pages = "5450--5459",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "40",

}

TY - JOUR

T1 - Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery

AU - Best, Simon R

AU - Peng, Shiwen

AU - Juang, Chi Mou

AU - Hung, Chien-Fu

AU - Hannaman, Drew

AU - Saunders, John R.

AU - Wu, Tzyy Choou

AU - Pai, Sara I.

PY - 2009/9/4

Y1 - 2009/9/4

N2 - DNA vaccines are an attractive approach to eliciting antigen-specific immunity. Intracellular targeting of tumor antigens through its linkage to immunostimulatory molecules such as calreticulin (CRT) can improve antigen processing and presentation through the MHC class I pathway and increase cytotoxic CD8+ T cell production. However, even with these enhancements, the efficacy of such immunotherapeutic strategies is dependent on the identification of an effective route and method of DNA administration. Electroporation and gene gun-mediated particle delivery are leading methods of DNA vaccine delivery that can generate protective and therapeutic levels of immune responses in experimental models. In this study, we perform a head-to-head comparison of three methods of vaccination - conventional intramuscular injection, electroporation-mediated intramuscular delivery, and epidermal gene gun-mediated particle delivery - in the ability to generate antigen-specific cytotoxic CD8+ T cell responses as well as anti-tumor immune responses against an HPV-16 E7 expressing tumor cell line using the pNGVL4a-CRT/E7(detox) DNA vaccine. Vaccination via electroporation generated the highest number of E7-specific cytotoxic CD8+ T cells, which correlated to improved outcomes in the treatment of growing tumors. In addition, we demonstrate that electroporation results in significantly higher levels of circulating protein compared to gene gun or intramuscular vaccination, which likely enhances calreticulin's role as a local tumor anti-angiogenesis agent. We conclude that electroporation is a promising method for delivery of HPV DNA vaccines and should be considered for DNA vaccine delivery in human clinical trials.

AB - DNA vaccines are an attractive approach to eliciting antigen-specific immunity. Intracellular targeting of tumor antigens through its linkage to immunostimulatory molecules such as calreticulin (CRT) can improve antigen processing and presentation through the MHC class I pathway and increase cytotoxic CD8+ T cell production. However, even with these enhancements, the efficacy of such immunotherapeutic strategies is dependent on the identification of an effective route and method of DNA administration. Electroporation and gene gun-mediated particle delivery are leading methods of DNA vaccine delivery that can generate protective and therapeutic levels of immune responses in experimental models. In this study, we perform a head-to-head comparison of three methods of vaccination - conventional intramuscular injection, electroporation-mediated intramuscular delivery, and epidermal gene gun-mediated particle delivery - in the ability to generate antigen-specific cytotoxic CD8+ T cell responses as well as anti-tumor immune responses against an HPV-16 E7 expressing tumor cell line using the pNGVL4a-CRT/E7(detox) DNA vaccine. Vaccination via electroporation generated the highest number of E7-specific cytotoxic CD8+ T cells, which correlated to improved outcomes in the treatment of growing tumors. In addition, we demonstrate that electroporation results in significantly higher levels of circulating protein compared to gene gun or intramuscular vaccination, which likely enhances calreticulin's role as a local tumor anti-angiogenesis agent. We conclude that electroporation is a promising method for delivery of HPV DNA vaccines and should be considered for DNA vaccine delivery in human clinical trials.

KW - Calreticulin (CRT)

KW - DNA vaccine

KW - Electroporation

KW - Head and neck cancer

KW - Human papillomavirus (HPV)

UR - http://www.scopus.com/inward/record.url?scp=68349152636&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=68349152636&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2009.07.005

DO - 10.1016/j.vaccine.2009.07.005

M3 - Article

VL - 27

SP - 5450

EP - 5459

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 40

ER -